Semaglutide 2.4 mg once weekly is the latest approved GLP-1 RA for obesity management (2021) and results in 1517% mean WL through appetite reduction [11, 12]
Both Wegovy and metformin can affect the digestive system, so taking them together might increase the chance of side effects
Are there better alternatives if I want real GLP-1 care
If you are new to subcutaneous injections entirely, the beginner peptide injection guide covers fundamentals like needle selection, air bubble removal, and anxiety management
Investigated for profound roles in hepatic lipid metabolism and adipose tissue modulation
In a study published in the New England Journal of Medicine , participants using Semaglutide lost up to 15% of their body weight over 68 weeks, compared to 2.4% in the placebo group